Cardiac Arrhythmia
Expert
Member of
Medical Advisory Committee
at Cambridge Heart Clinic
Cambridge Heart Clinic
Addenbrooke's Hospital,
Cambridge University Hospitals
NHS Foundation Trust,
Cambridge, United Kingdom
CB2 0QQ
​
About Dr Heck
Dr Heck was appointed a Consultant Cardiologist in 2012 and was awarded membership of the Medical Advisory Committee of Cambridge Heart Clinic in 2020.
Dr Heck completed his undergraduate training in medicine at Cambridge University (Gonville and Caius College) in 1997 and later graduated from clinical school at Oxford University in 2000.
After completing his junior doctor training, Dr Heck undertook his specialist training in Cardiology in Cambridge before completing a period of post-graduate clinical research for he was awarded a Doctor of Medicine (DM) from Oxford University in 2010.
He then completed an 18-month Electrophysiology Fellowship at the Royal Melbourne Hospital, Australia, one of the world’s leading centres in cardiac electrophysiology.
​
His areas of major interest are ablation of all cardiac arrhythmias, including atrial fibrillation and ventricular tachycardia. Additionally, he is interested in complex device implantation (ICDs and CRT) and is trained in device extraction.
​
Specialist clinical interests
Arrhythmias, Catheter Ablation, Device Extractions, Atrial Fibrillation, Ventricular Tachycardia, Complex Device Therapy
​
Research interests
Atrial Fibrillation, Cardiac Resynchronisation Therapy.
​
Education and training
BA Mammalian Physiology (Cambridge) 1997
BM BCh (Oxford) 2000
MA (Oxford) 2001
MRCP (UK) 2003
DM (Oxford) 2010
​
Current memberships
Member of the Royal College of Physicians, London.
Member of the General Medical Council (registration number: 4731722).
Member of Heart Rhythm Society
Member of the British Cardiac Society
​
Declaration of interests
Dr Heck has declared that he does not hold a share or any financial interest in Cambridge Heart Clinic or any company owned by Regent’s Park Healthcare. This statement conforms with guidance set out by the Competition and Markets Authority.
Areas of Expertise
Research & Articles
Book Chapters
Heck P, Teh A, Kalman J: How to Ablate Atrial Tachycardias. In Al-Ahmad A, Callans D, Hsia H, Natale A, Oseroff O, Wang P, eds: Hands-On Ablation: The Experts' Approach: Cardiotext Publishing, in press.
​
Heck P, Fynn S: Cardiac Arrhythmias. In Hobbs R, Mcmanus RJ, Taylor CJ, eds: Cardiovascular Disease in Primary Care: Royal College of General Practitioners, 2011.
​
Journal Publications
Barra S, Providência R, Boveda S, Duehmke R, Narayanan K, Chow AW, Piot O, Klug D, Defaye P, Gras D, Deharo JC, Milliez P, Da Costa A, Mondoly P, Gonzalez-Panizo J, Leclercq C, Heck P, Virdee M, Sadoul N, Le Heuzey JY, Marijon E. Device complications with addition of defibrillation to cardiac resynchronisation therapy for primary prevention. Heart. 2018 Mar 14. pii: heart jnl-2017-312546.
Barra S, Duehmke R, Providencia R, Marijon E, Boveda S, Virdee M, Heck P, Fynn S, Begley D, Grace A, Agarwal S. Patients upgraded to cardiac resynchronization therapy due to pacing-induced cardiomyopathy are at low risk of life-threatening ventricular arrhythmias: a long-term cause-of-death analysis. Europace. 2018 Jan 1;20(1):89-96.
Sertic F, Bosco P, Ferrara A, Heck P, Abu-Omar Y. ICD lead extraction: Not a benign procedure. External chest compression: Not a benign manoeuvre. JRSM Cardiovasc Dis. 2017 Sep 12;6:2048004017731040.
Martin CA, Curtain JP, Gajendragadkar PR, Begley DA, Fynn SP, Grace AA, Heck PM, Salaunkey K, Virdee MS, Agarwal S. Improved outcome and cost effectiveness in ablation of persistent atrial fibrillation under general anaesthetic. Europace. 2017 Apr 21.
Barra S, Goonewardene M, Heck P, Begley D, Virdee M, Fynn S, Grace A, Agarwal S. Implantable cardioverter-defibrillator elective generator replacement: a procedure for all? J Interv Card Electrophysiol. 2016 Mar;45(2):209-18.
Barra S, Providência R, Tang A, Heck P, Virdee M, Agarwal S. Importance of Implantable Cardioverter-Defibrillator Back-Up in Cardiac Resynchronization Therapy Recipients: A Systematic Review and Meta-Analysis. J Am Heart Assoc. 2015 Nov 6;4(11). pii: e002539.
McCormick LM, Heck PM, Ring LS, Kydd AC, Clarke SJ, Hoole SP, Dutka DP. Glucagon-like peptide-1 protects against ischemic left ventricular dysfunction during hyperglycemia in patients with coronary artery disease and type 2 diabetes mellitus. Cardiovasc Diabetol. 2015 Aug 8;14:102.
McLellan AJ, Ling LH, Azzopardi S, Lee GA, Lee G, Kumar S, Wong MC, Walters TE, Lee JM, Looi KL, Halloran K, Stiles MK, Lever NA, Fynn SP, Heck PM, Sanders P, Morton JB, Kalman JM, Kistler PM. A minimal or maximal ablation strategy to achieve pulmonary vein isolation for paroxysmal atrial fibrillation: a prospective multi-centre randomized controlled trial (the Minimax study). Eur Heart J. 2015 Jul 21;36(28):1812-21
Barra S, Begley D, Heck P, Turner I, Agarwal S. Ablation of ventricular tachycardia in the very elderly patient with cardiomyopathy: how old is too old? Can J Cardiol. 2015 Jun;31(6):717-22.
Goonewardene M, Barra S, Heck P, Begley D, Fynn S, Virdee M, Grace A, Agarwal S. Cardioverter-defibrillator implantation and generator replacement in the octogenarian. Europace. 2015 Mar;17(3):409-16.
Barra S, Providência R, Paiva L, Heck P, Agarwal S. Implantable cardioverter-defibrillators in the elderly: rationale and specific age-related considerations. Europace. 2015 Feb;17(2):174-86.
Kumar S, Brown G, Sutherland F, Morgan J, Andrews D, Ling LH, McLELLAN AJ, Lee G, Robinson T, Heck P, Halloran K, Morton J, Kistler P, Kalman JM, Sparks PB. The transesophageal echo probe may contribute to esophageal injury after catheter ablation for paroxysmal atrial fibrillation under general anesthesia: a preliminary observation. J Cardiovasc Electrophysiol. 2015 Feb;26(2):119-26
Consultant Cardiologist
Dr Patrick Heck
Practice Location
Cambridge Heart Clinic
Addenbrooke's Hospital,
Cambridge University Hospitals
NHS Foundation Trust,
Cambridge, United Kingdom
CB2 0QQ
​
Tel: +44 (0)1223 857474